China unveiled multiple countermeasures on Tuesday, immediately after new U.S. tariffs on its imports took effect. This marks ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Detailed price information for GX Genomics & Biotechnology ETF (GNOM-Q) from The Globe and Mail including charting and trades.

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Ark Invest’s decision to sell Palantir Technologies Inc. PLTR shares on Thursday comes amid a backdrop of competitive pressures in the AI space. Recently, Palantir has faced challenges from ...

Professor Aldrin Gomes of the Department of Neurobiology, Physiology and Behavior, second from right, was named a recipient of the Presidential Award for Excellence in Science, Mathematics and ...

However, scaling microbial fermentation from the lab bench to manufacture can be challenging, particularly against an evolving regulatory backdrop. While some biopharmaceutical companies opt to take ...

Sorted single-cell suspensions were resuspended at an estimated final concentration of 270, 1150 and 1450 cells/μl and loaded on a Chromium GemCode Single Cell Instrument (10x Genomics) to generate ...

What is multi-omics? Multi-omics is the integration of multiple omic data during analysis. Omic data principally includes genomics, transcriptomics, proteomics, epigenomics and metabolomics, among ...